Diederik Stadig

Share

Portrait of Diederik Stadig

Senior Economist, Healthcare & Technology

Diederik Stadig is Healthcare and Technology economist at ING Research. He joined the firm in 2023 and previously worked as lecturer at de Vrije Universiteit Amsterdam. He holds a PhD in political economy from the same university.

Diederik Stadig

diederik.stadig@ing.com

Latest reports from Diederik

Telecom Outlook 2025: A high-frequency future

Telecom Outlook 2025: A high-frequency future

The full report on why 2025 promises to be an exciting year for European telecoms

Telecoms Outlook 2024: Stepping into the future

Telecoms Outlook 2024: Stepping into the future

2024 will be the year of the smart home, the acceleration of Europe’s fibre rollout, transformative M&A and opportunities around 5G and cyber security

Latest opinion

Dutch medicine shortage gets even worse

By Diederik Stadig

Dutch medicine shortage gets even worse

The Dutch medicine shortage increased by 51% last year.

Latest podcasts

Listen: Pharma 2026 - higher prices, manufacturing migration, China's ascent

Listen: Pharma 2026 - higher prices, manufacturing migration, China's ascent

Listen: The data centre power play - AI, energy and Europe's next move

Listen: The data centre power play - AI, energy and Europe's next move

More from Diederik

Trump's 100% pharma tariffs will have a limited effect on the sector

Trump's 100% pharma tariffs will have a limited effect on the sector

This new tariff appears driven by geopolitical considerations, limiting the economic impact

Watch: European pharma's fight to stay relevant

Europe's pharmaceutical industry is being squeezed by China and the US

Webinar: Europe's housing markets in a volatile world

Webinar: Europe's housing markets in a volatile world

ING's experts will explain what higher interest rates, supply shortages and regulatory change mean for Europe's housing sector

Commodities, Food & Agri

Transformative or overhyped? The impact of weight-loss drugs on European food demand

Transformative or overhyped? The impact of weight-loss drugs on European food demand

Europe’s last chance to revive its pharmaceutical innovation power

Europe’s last chance to revive its pharmaceutical innovation power

Pharma’s Godfather moment: pulled back into tariff uncertainty

Pharma’s Godfather moment: pulled back into tariff uncertainty

Transport & Logistics

Manufacturing, Construction and Retail

3 calls for EU sectors in 2026: Tech outperformance, manufacturing growth gaps, small consumer gains

3 calls for EU sectors in 2026: Tech outperformance, manufacturing growth gaps, small consumer gains